Evidence so far suggests that the prevalence of long COVID in low- and middle-income countries could be similar to that of wealthier countries. For example, by some estimates, more than four million people in Brazil have long COVID.
However, an absence of research on the condition in less-wealthy countries has left advocates hamstrung: few physicians acknowledge that long COVID exists. A lack of data is also hampering efforts to search for the mechanisms of the condition and tailor treatments.
This is an audio version of our Feature Long COVID is a double curse in low-income nations — here’s why
Hosted on Acast. See acast.com/privacy for more information.
Coronapod: Will COVID become a disease of the young?
Food shocks and how to avoid them
Coronapod: the biomarker that could change COVID vaccines
The scientist whose hybrid rice helped feed billions
Audio long-read: How COVID exposed flaws in evidence-based medicine
Coronapod: should you have a COVID vaccine when breastfeeding?
Quantum compass might help birds 'see' magnetic fields
CureVac disappoints in COVID vaccine trial
Communities, COVID and credit: the state of science collaborations
Coronapod: Counting the cost of long COVID
Google AI beats humans at designing computer chips
Coronapod: Uncertainty and the COVID 'lab-leak' theory
On the origin of numbers
New hope for vaccine against a devastating livestock disease
Audio long-read: How harmful are microplastics?
The 'zombie' fires that keep burning under snow-covered forests
Coronapod: The variant blamed for India's catastrophic second wave
The brain implant that turns thoughts into text
Coronapod: Waiving vaccine patents and coronavirus genome data disputes
Oldest African burial site uncovers Stone Age relationship with death
Create your
podcast in
minutes
It is Free
More or Less: Behind the Stats
NPP BrainPod
Pediatric Research Podcast
Eye Podcast